The first half of 2010 has been a particularly busy time for Optometry and Vision Science (OVS). By the end of May, our Editorial office received twice as many manuscript submissions as it had at the same time in 2009. In fact, it was the end of September 2009 before we had the equivalent number of submissions in 2009.
This manuscript “traffic” has kept the Editor-in-Chief, Managing Editor, the Editorial Board, and its Guest Topical Editors quite busy, and reviewers, who are a key to our success, have had their share of increased activity. Our Editorial Board sees this as a healthy state of affairs for OVS as it moves into new publication paradigms with its publisher Lippincott Williams & Wilkins (LWW).
At the time of writing this Editorial (end of May), OVS has all of its articles scheduled for publication through the end of September, with most of its Glaucoma feature issue articles accepted for publication beyond that. When you receive this month’s publication, all scheduled articles through the end of September will be available as e-publications (published ahead of print) accessible at the OVS web site. In short, we are now targeting e-pubs for as much as 3 months ahead of publication.
Ahead of us lies an upcoming feature issue entirely focused on glaucoma with internationally recognized clinicians and researchers as Guest Editors. Academy fellows Chris Johnson (University of Iowa, Iowa) and Murray Fingeret (New York, New York) are working with ophthalmology glaucoma specialist colleagues Douglas Anderson (University of Miami, Florida) and David Garway-Heath (University College, London).
This month (July 26 to 29), the 13th International Myopia Conference (http://www.imc-2010.org/program.html) will be held in Tübingen, Germany. OVS will be publishing a Myopia issue that will include the conference proceedings abstracts and posters, along with selected key conference papers and a Guest Editorial, lead by Frank Schaeffel (University of Tübingen, Germany). The Guest Editorial will place the most recently reported advances in myopia research and treatment in context. OVS produced a similar theme issue (published January 2009) for the 12th Biannual International Myopia Conference held in Australia in 2008.
Finally, I am exploring a theme issue on Amblyopia and its treatment, including new concepts and methods for treating adults with amblyopia. So, we have been very busy and expect to remain busy throughout the year. I see this as challenging, but very positive in the sense that we have wonderful new opportunities to communicate the very best of research that has clinical impact. I am grateful for an increasingly appreciative readership and to our expanded cadre of excellent authors.
Anthony J. Adams